Barkley PMHNP Chapter Quiz 4 v2.0: Advanced
Psychiatric-Mental Health Nurse Practitioner
Examination a well detailed one written
and graded A+ upgraded Comprehensive Assessment
on Neurobiology, Psychopharmacology, Psychotherapy,
Professional Role, and Evidence-Based Practice
Instructions
This 150-question multiple-choice examination is designed for advanced practice psychiatric-
mental health nurse practitioner (PMHNP) students and professionals. Questions are written at
an advanced/hard difficulty level and cover the breadth of content expected for certification.
Select the single best answer for each question. Each question includes a detailed rationale for
the correct answer and explanations for incorrect options.
Section A: Neurobiology and Pathophysiology (Questions 1-30)
1. A 32-year-old patient with schizophrenia demonstrates significant negative symptoms
including avolition, alogia, and affective flattening. These symptoms are most closely
associated with dysfunction in which brain region and neurotransmitter system?
A) Mesolimbic dopamine pathway hyperactivity
B) Mesocortical dopamine pathway hypofunction
C) Nigrostriatal dopamine pathway dysfunction
D) Tuberoinfundibular dopamine pathway hyperactivity
Correct Answer: B
Rationale: Negative symptoms of schizophrenia are primarily associated with hypofunction of
the mesocortical dopamine pathway projecting to the prefrontal cortex. This results in reduced
dopaminergic tone in the prefrontal cortex, contributing to avolition, alogia, and affective
,flattening. Mesolimbic hyperactivity is associated with positive symptoms, nigrostriatal
dysfunction with extrapyramidal symptoms, and tuberoinfundibular dysfunction with
hyperprolactinemia.
2. A patient with major depressive disorder is found to have elevated cortisol levels and
failure of dexamethasone suppression. This finding is most consistent with dysfunction of
which neuroendocrine axis?
A) Hypothalamic-pituitary-thyroid (HPT) axis
B) Hypothalamic-pituitary-adrenal (HPA) axis
C) Hypothalamic-pituitary-gonadal (HPG) axis
D) Renin-angiotensin-aldosterone system
Correct Answer: B
Rationale: HPA axis hyperactivity is a well-established finding in major depressive disorder,
characterized by hypercortisolemia and failure of dexamethasone to suppress cortisol secretion
(dexamethasone non-suppression). This reflects impaired negative feedback regulation of the
HPA axis at the level of the hippocampus and hypothalamus.
3. A 45-year-old patient with chronic PTSD has been found to have reduced hippocampal
volume on neuroimaging. The most likely mechanism for this finding is:
A) Genetic predisposition only
B) Chronic stress-induced glucocorticoid neurotoxicity
C) Reduced blood flow to the hippocampus
D) Neurodevelopmental abnormality
Correct Answer: B
Rationale: Chronic stress and PTSD are associated with elevated cortisol levels, which can have
neurotoxic effects on hippocampal neurons through glucocorticoid receptor-mediated
mechanisms. This leads to dendritic atrophy, reduced neurogenesis, and decreased
hippocampal volume. While genetics and development may play roles, the stress-glucocorticoid
mechanism is the primary explanation.
4. Which neurotransmitter system is most directly involved in the pathophysiology of
obsessive-compulsive disorder (OCD) and is the primary target of first-line pharmacotherapy?
A) Dopamine
B) Serotonin
C) Norepinephrine
D) Glutamate
,Correct Answer: B
Rationale: The serotonin system is critically involved in OCD pathophysiology, as evidenced by
the efficacy of SSRIs (which increase serotonin availability) in treating OCD. The cortico-striato-
thalamo-cortical (CSTC) circuit, which is modulated by serotonin, is hyperactive in OCD. While
dopamine and glutamate also play roles, serotonin is the primary target of first-line
pharmacotherapy.
5. A patient with Alzheimer's disease is being treated with memantine. The primary
mechanism of action of memantine involves:
A) Acetylcholinesterase inhibition
B) NMDA receptor antagonism
C) Dopamine receptor agonism
D) Serotonin reuptake inhibition
Correct Answer: B
Rationale: Memantine is an NMDA receptor antagonist that modulates glutamate activity. It is
thought to work by reducing excitotoxicity (excessive glutamate stimulation) in the brain, which
contributes to cognitive decline in Alzheimer's disease. Acetylcholinesterase inhibition is the
mechanism of donepezil, rivastigmine, and galantamine.
6. A 28-year-old patient with panic disorder experiences recurrent, unexpected panic attacks.
The neurobiological basis of panic disorder involves hyperactivity in which brain structure?
A) Prefrontal cortex
B) Amygdala
C) Locus coeruleus
D) Hippocampus
Correct Answer: C
Rationale: The locus coeruleus is the primary source of norepinephrine in the brain and is
critically involved in the "fight-or-flight" response. Hyperactivity of the locus coeruleus-
norepinephrine system is implicated in panic disorder, contributing to autonomic hyperarousal
and panic attacks. While the amygdala is involved in fear processing, the locus coeruleus is more
specifically linked to panic symptomatology.
7. A patient with schizophrenia is being treated with a first-generation antipsychotic and
develops tardive dyskinesia. The pathophysiology of tardive dyskinesia most likely involves:
A) Dopamine D2 receptor upregulation in the striatum
B) Serotonin 5-HT2A receptor downregulation
, C) GABA-A receptor upregulation
D) Acetylcholine receptor upregulation
Correct Answer: A
Rationale: Tardive dyskinesia results from chronic D2 receptor blockade leading to
compensatory upregulation (supersensitivity) of D2 receptors in the striatum. This receptor
supersensitivity results in abnormal involuntary movements, particularly orofacial dyskinesias.
The risk is higher with first-generation antipsychotics and increases with duration of treatment.
8. The "glutamate hypothesis" of schizophrenia proposes that:
A) Glutamate is decreased in schizophrenia
B) Glutamate is increased in schizophrenia and contributes to excitotoxicity
C) NMDA receptor hypofunction leads to downstream dopamine dysregulation
D) Glutamate has no role in schizophrenia
Correct Answer: C
Rationale: The glutamate hypothesis proposes that NMDA receptor hypofunction (particularly
in the prefrontal cortex and hippocampus) leads to downstream dopamine dysregulation,
contributing to both positive and negative symptoms of schizophrenia. This hypothesis is
supported by the psychotomimetic effects of NMDA receptor antagonists (e.g., PCP, ketamine).
9. A patient with bipolar disorder is being treated with lithium. Lithium's mechanism of action
in mood stabilization involves:
A) Direct inhibition of dopamine release
B) Enhancement of serotonin synthesis
C) Inhibition of glycogen synthase kinase-3 (GSK-3) and inositol monophosphatase
D) GABA-A receptor potentiation
Correct Answer: C
Rationale: Lithium inhibits glycogen synthase kinase-3 (GSK-3) and inositol monophosphatase,
leading to modulation of intracellular signaling pathways involved in neuroplasticity and mood
regulation. These effects are thought to contribute to lithium's mood-stabilizing properties.
Lithium does not directly inhibit dopamine release, enhance serotonin synthesis, or potentiate
GABA-A receptors.
10. A patient with alcohol use disorder develops Wernicke's encephalopathy. The classic triad
of Wernicke's encephalopathy includes:
A) Confusion, ataxia, and ophthalmoplegia
B) Tremor, hallucinations, and seizures
Psychiatric-Mental Health Nurse Practitioner
Examination a well detailed one written
and graded A+ upgraded Comprehensive Assessment
on Neurobiology, Psychopharmacology, Psychotherapy,
Professional Role, and Evidence-Based Practice
Instructions
This 150-question multiple-choice examination is designed for advanced practice psychiatric-
mental health nurse practitioner (PMHNP) students and professionals. Questions are written at
an advanced/hard difficulty level and cover the breadth of content expected for certification.
Select the single best answer for each question. Each question includes a detailed rationale for
the correct answer and explanations for incorrect options.
Section A: Neurobiology and Pathophysiology (Questions 1-30)
1. A 32-year-old patient with schizophrenia demonstrates significant negative symptoms
including avolition, alogia, and affective flattening. These symptoms are most closely
associated with dysfunction in which brain region and neurotransmitter system?
A) Mesolimbic dopamine pathway hyperactivity
B) Mesocortical dopamine pathway hypofunction
C) Nigrostriatal dopamine pathway dysfunction
D) Tuberoinfundibular dopamine pathway hyperactivity
Correct Answer: B
Rationale: Negative symptoms of schizophrenia are primarily associated with hypofunction of
the mesocortical dopamine pathway projecting to the prefrontal cortex. This results in reduced
dopaminergic tone in the prefrontal cortex, contributing to avolition, alogia, and affective
,flattening. Mesolimbic hyperactivity is associated with positive symptoms, nigrostriatal
dysfunction with extrapyramidal symptoms, and tuberoinfundibular dysfunction with
hyperprolactinemia.
2. A patient with major depressive disorder is found to have elevated cortisol levels and
failure of dexamethasone suppression. This finding is most consistent with dysfunction of
which neuroendocrine axis?
A) Hypothalamic-pituitary-thyroid (HPT) axis
B) Hypothalamic-pituitary-adrenal (HPA) axis
C) Hypothalamic-pituitary-gonadal (HPG) axis
D) Renin-angiotensin-aldosterone system
Correct Answer: B
Rationale: HPA axis hyperactivity is a well-established finding in major depressive disorder,
characterized by hypercortisolemia and failure of dexamethasone to suppress cortisol secretion
(dexamethasone non-suppression). This reflects impaired negative feedback regulation of the
HPA axis at the level of the hippocampus and hypothalamus.
3. A 45-year-old patient with chronic PTSD has been found to have reduced hippocampal
volume on neuroimaging. The most likely mechanism for this finding is:
A) Genetic predisposition only
B) Chronic stress-induced glucocorticoid neurotoxicity
C) Reduced blood flow to the hippocampus
D) Neurodevelopmental abnormality
Correct Answer: B
Rationale: Chronic stress and PTSD are associated with elevated cortisol levels, which can have
neurotoxic effects on hippocampal neurons through glucocorticoid receptor-mediated
mechanisms. This leads to dendritic atrophy, reduced neurogenesis, and decreased
hippocampal volume. While genetics and development may play roles, the stress-glucocorticoid
mechanism is the primary explanation.
4. Which neurotransmitter system is most directly involved in the pathophysiology of
obsessive-compulsive disorder (OCD) and is the primary target of first-line pharmacotherapy?
A) Dopamine
B) Serotonin
C) Norepinephrine
D) Glutamate
,Correct Answer: B
Rationale: The serotonin system is critically involved in OCD pathophysiology, as evidenced by
the efficacy of SSRIs (which increase serotonin availability) in treating OCD. The cortico-striato-
thalamo-cortical (CSTC) circuit, which is modulated by serotonin, is hyperactive in OCD. While
dopamine and glutamate also play roles, serotonin is the primary target of first-line
pharmacotherapy.
5. A patient with Alzheimer's disease is being treated with memantine. The primary
mechanism of action of memantine involves:
A) Acetylcholinesterase inhibition
B) NMDA receptor antagonism
C) Dopamine receptor agonism
D) Serotonin reuptake inhibition
Correct Answer: B
Rationale: Memantine is an NMDA receptor antagonist that modulates glutamate activity. It is
thought to work by reducing excitotoxicity (excessive glutamate stimulation) in the brain, which
contributes to cognitive decline in Alzheimer's disease. Acetylcholinesterase inhibition is the
mechanism of donepezil, rivastigmine, and galantamine.
6. A 28-year-old patient with panic disorder experiences recurrent, unexpected panic attacks.
The neurobiological basis of panic disorder involves hyperactivity in which brain structure?
A) Prefrontal cortex
B) Amygdala
C) Locus coeruleus
D) Hippocampus
Correct Answer: C
Rationale: The locus coeruleus is the primary source of norepinephrine in the brain and is
critically involved in the "fight-or-flight" response. Hyperactivity of the locus coeruleus-
norepinephrine system is implicated in panic disorder, contributing to autonomic hyperarousal
and panic attacks. While the amygdala is involved in fear processing, the locus coeruleus is more
specifically linked to panic symptomatology.
7. A patient with schizophrenia is being treated with a first-generation antipsychotic and
develops tardive dyskinesia. The pathophysiology of tardive dyskinesia most likely involves:
A) Dopamine D2 receptor upregulation in the striatum
B) Serotonin 5-HT2A receptor downregulation
, C) GABA-A receptor upregulation
D) Acetylcholine receptor upregulation
Correct Answer: A
Rationale: Tardive dyskinesia results from chronic D2 receptor blockade leading to
compensatory upregulation (supersensitivity) of D2 receptors in the striatum. This receptor
supersensitivity results in abnormal involuntary movements, particularly orofacial dyskinesias.
The risk is higher with first-generation antipsychotics and increases with duration of treatment.
8. The "glutamate hypothesis" of schizophrenia proposes that:
A) Glutamate is decreased in schizophrenia
B) Glutamate is increased in schizophrenia and contributes to excitotoxicity
C) NMDA receptor hypofunction leads to downstream dopamine dysregulation
D) Glutamate has no role in schizophrenia
Correct Answer: C
Rationale: The glutamate hypothesis proposes that NMDA receptor hypofunction (particularly
in the prefrontal cortex and hippocampus) leads to downstream dopamine dysregulation,
contributing to both positive and negative symptoms of schizophrenia. This hypothesis is
supported by the psychotomimetic effects of NMDA receptor antagonists (e.g., PCP, ketamine).
9. A patient with bipolar disorder is being treated with lithium. Lithium's mechanism of action
in mood stabilization involves:
A) Direct inhibition of dopamine release
B) Enhancement of serotonin synthesis
C) Inhibition of glycogen synthase kinase-3 (GSK-3) and inositol monophosphatase
D) GABA-A receptor potentiation
Correct Answer: C
Rationale: Lithium inhibits glycogen synthase kinase-3 (GSK-3) and inositol monophosphatase,
leading to modulation of intracellular signaling pathways involved in neuroplasticity and mood
regulation. These effects are thought to contribute to lithium's mood-stabilizing properties.
Lithium does not directly inhibit dopamine release, enhance serotonin synthesis, or potentiate
GABA-A receptors.
10. A patient with alcohol use disorder develops Wernicke's encephalopathy. The classic triad
of Wernicke's encephalopathy includes:
A) Confusion, ataxia, and ophthalmoplegia
B) Tremor, hallucinations, and seizures
